p53 and follow-up of colorectal adenocarcinomas

Digestive Diseases and Sciences

Volumn 43, Issue 7, 1998, Pages 1434-1442

  Polge, Anne ^b   Bourgaux, Jean Francois ^b   Bancel, Etiennette ^b   Pignodel, Christine ^b   Boyer, Jean Christophe ^b   Poirey, Sophie ^b   De Bornier, Bernard Magnan ^b   Balmes, Jean Louis ^b   Bali, Jean Pierre ^a  

^a DEPARTMENT OF NEUROLOGY   (France)

^b NONE

Author keywords

Colorectal adenocarcinoma; P53; P53 antibodies; TP53 gene mutations

Indexed keywords

ANTIBODY; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; FLUOROURACIL; FOLINIC ACID; PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GENES, P53; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031818975     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018890126260     Document Type: Article

References (33)

1. Greenblatt MS, Bennet WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994
2. Levine AJ, Perry ME, Chang A: The role of p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416, 1994
3. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholtz B: Multifactorial analysis of p53 alteration in human cancer: A review. Int J Cancer 57:1-9, 1994
4. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselin B, Remvikos Y: Association of p53 mutations with short survival in colorectal cancer. Gastroenterol 106:42-48, 1994
5. Baker SJ, Fearon ER, Nigro JM: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217-221, 1989
6. Porter PL, Gown AM, Kramp SG, Coltrera MD: Widespread p53 overexpression in human malignant tumours. Am J Pathol 140:145-153, 1992
7. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms a hsp70-p53 complex with an altered half life. Mol Cell Biol 8:531-539, 1988
8. Schlichtholtz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo I, Soussi T: The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 52:6380-6384, 1992
9. Labrecque S, Naor N, Thompson D, Matlashewski G: Analysis of the anti-p53 response in cancer patients. Cancer Res 53:3468-3471, 1993
10. Lubin R, Schlichtholz B, Teillaud JL, Garay E, Bussel A, Wild CP, Soussi T: p53 antibodies in patients with various types of cancer: Identification and characterization. Clin Cancer Res 1:1463-1469, 1995
11. Davidoff AM, Iglehart JD, Marks JR: Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci USA 89:3439-3442, 1992
12. Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP: Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 52:4168-4174, 1992
13. Müller M, Volkmann M, Zentgraf H, Galle P: Clinical implications of the p53 tumour-suppressor gene. N Engl J Med 330:865, 1994 (letter)
14. Campani D, Cecchetti D, Bevilacqua G: Immunocytochemical p53 detection by microwave oven heating of routinely formalin-fixed paraffin sections. J Pathol 171:151-152, 1993
15. Jiko K, Sasano H, Ito K, Ozawa N, Sato S, Yajima A: Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus. Anticancer Res 13:305-310, 1993
16. Lassam NJ, From L, Kahn HJ: Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 53:2235-2238, 1993
17. Baas IO, Mulder JWR, Hofferhaus GJA, Vogelstein B, Hamilton SR: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasm. J Pathol 172:5-12, 1994
18. Kressner ULF, Lindmark G, Gerdin B, Pahlman L, Glimelius B: Immunohistochemical p53 staining is of limited value in the staging and pronostic prediction of colorectal cancer. Anticancer Res 16:951-958, 1996
19. Hammel P, Boissier B, Chaumette MT, Piebois P, Rotman N, Kouyoumdjian JC, Lubin R, Delchier JC, Soussi T: Detection and monitoring of serum p53 antibodies in patients with colorectal cancer. Gut 40:356-361, 1997
20. Crawford LV, Pim DC, Bulbrook RD: Detection of antibodies against the cellular protein p53 in the sera from patients with breast cancer. Int J Cancer 30:403-408, 1982
21. Volkmann M, Müller M, Hofmann J, Meyer M, Hagelstein J, Ruth U, Kommerell B, Zentgraf H, Galle PR: The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α-fetoprotein status. Hepatology 18:559-565, 1993
22. Angelopoulou K, Diamandis EP: Autoantibodies against the p53 tumour suppressor gene product quantified in cancer patient serum with time-resolved immunofluorometry. Cancer J 6:315-321, 1993
23. Lubin R, Schlichtholz B, Bengoufa D, Zalcman G, Tredaniel J, Hirsch A: Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface. Cancer Res 53:5872-5876, 1993
24. Mudenda B, Green JA, Green B, Jenkins JR, Robertson L, Tarunina M, Leinster SJ: The relationship between serum p53 autoantibodies and characteristics of human breast cancer. Br J Cancer 69:1115-1119, 1994
25. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83, 1992
26. Barnes DM, Hanby AM, Gillett CE, Mohamed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, Mac Geoch C, Spurr NK, Bartek J, Vojtesek B, Pickseley M, Lane DP: Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340:259-263, 1992
27. Hall PA, McKee PH, Du P, Menage H, Dover R, Lane DP: High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203-207, 1993
28. Preudhomme C, Lubin R, Lepelley P, Vanrumbeke M, Fenaux P: Detection of serum anti-p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 8:1589-1591, 1994
29. Wild CP, Ridanpää M, Anttila S, Lubin S, Soussi T, HusgafvelPursiainen K, Vanino H: p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutations in the tumour tissue. Int J Cancer 64:176-181, 1995
30. Shibata Y, Kotanagi H, Andoh H, Koyama K, Itoh H, Kudo SE: Detection of circulating anti-p53 antibodies in patients with colorectal carcinoma and the antibody's relation to clinical factors. Dis Colon Rectum 39: 1269-1274, 1996
31. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EMG: p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers. Oncogene 10:681-688, 1995
32. Bertorelle R, Esposito G, Belluco C, Bonaldi L, Del Mistro A, Nitti D, Lise M, Chieco-Bianchi L: p53 gene alterations and protein accumulation in colorectal cancer. J Clin Pathol Mol Pathol 49:M86-M90, 1996
33. Houbiers JGA, Van der Burg SH, Van de Watering LMG, Tollenaar RAEM, Brand A, Van de Velde CJH, Melief CJM: Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br J Cancer 72:637-641, 1995